CRAMs

Capot is committed to providing global pharmaceutical companies with exceptional Contract Research and Manufacturing Services (CRAMS). Our goal is to assist clients in controlling R&D costs, enhancing production efficiency, and accelerating the market entry of new drugs through high-quality, efficient outsourcing partnerships.

Core Service Areas:

• Regulatory Starting Materials (RSMs): Offering high-purity, high-reliability starting materials for pharmaceutical R&D.
• Key Intermediates (KIs): Specializing in the production of key regulatory intermediates that meet stringent regulatory requirements, aiding clients in the smooth development and registration of new drugs.
• GMP Compliant Intermediates (GMP CIs): Producing intermediates in accordance with Good Manufacturing Practice (GMP), ensuring compliance with international research and commercialization regulations.

Service Highlights:

• Technical Optimization and Innovation: Enhancing synthetic efficiency and reducing production costs through proprietary technological innovations, while addressing challenges in the synthesis process.
• Project Management Efficiency: Ensuring timely delivery of high-quality outcomes, meeting client needs with extensive project management experience.
• Advanced Production Technology: Employing the latest chemical reactions, purification techniques, and process optimizations to continuously improve product quality and production efficiency.
• Strict Quality Control: Adhering to cGMP and non-GMP standards, ensuring compliance with international research and commercialization requirements.

Competitive Advantages:

Capot leverages local production strengths and a global perspective to provide cost-effective service solutions for the international market. Our global clients, through partnerships with Capot, not only achieve effective cost control but also accelerate the product-to-market process, standing out in the global market.

With our outstanding performance in chemical synthesis, quality management, and customer service, Capot has become a trusted CRAMS service provider. We look forward to collaborating with global pharmaceutical enterprises to advance the development of medical science and move towards a more brilliant future together.